452 results on '"Macary, Paul A."'
Search Results
2. Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines
3. An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.
4. Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individuals
5. Single-shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immunity in mice
6. Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2
7. Platform for the interdisciplinary study of cardiovascular, metabolic and neurovascular diseases (PICMAN) protocol
8. Defining neutralization and allostery by antibodies against COVID-19 variants
9. Author Correction: An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis
10. Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly
11. CD28-CAR-T cell activation through FYN kinase signaling rather than LCK enhances therapeutic performance
12. The rapid progress in COVID vaccine development and implementation
13. Defining the specificity and function of a human neutralizing antibody for Hepatitis B virus
14. Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
15. Single shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immune responses in mice.
16. Protocol for structural modeling of antibody to human leukocyte antigen interaction using discovery and targeted cross-linking mass spectrometry
17. Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas.
18. Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19.
19. Association of systemic vitamin D on the course of dengue virus infection in adults: a single-centre dengue cohort study at a large institution in Singapore.
20. No crossreactivity of anti-SARS-CoV-2 spike protein antibodies with Syncytin-1
21. Blomia tropicalis–Specific TCR Transgenic Th2 Cells Induce Inducible BALT and Severe Asthma in Mice by an IL-4/IL-13–Dependent Mechanism
22. A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies
23. cGAS–STING cytosolic DNA sensing pathway is suppressed by JAK2-STAT3 in tumor cells
24. Codominant IgG and IgA expression with minimal vaccine mRNA in milk of BNT162b2 vaccinees
25. The trinity of COVID-19: immunity, inflammation and intervention
26. Analyzing COVID-19 Vaccine Responses in Transplant Recipients
27. Hybrid structural modeling of alloantibody binding to human leukocyte antigen with rapid and reproducible cross-linking mass spectrometry
28. Platelet TLR7 is essential for the formation of platelet–neutrophil complexes and low-density neutrophils in lupus nephritis
29. Employment of a high-throughput functional assay to define the critical factors that influence vaccine-induced, cross-variant neutralizing antibodies for SARS-CoV-2.
30. Defining the structural basis for human leukocyte antigen reactivity in clinical transplantation
31. Mobilization of MHC Class I Molecules from Late Endosomes to the Cell Surface Following Activation of CD34-Derived Human Langerhans Cells
32. NK cells are activated and primed for skin-homing during acute dengue virus infection in humans
33. SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade
34. The generation of rat ova-specific, MHC - class 1 restricted, IgE inhibitory, CD8+ T cell, clones
35. Targeting Epstein-Barr virus–transformed B lymphoblastoid cells using antibodies with T-cell receptor–like specificities
36. The other side of the coin: Leveraging Epstein–Barr virus in research and therapy
37. Characterisation of a human antibody that potentially links cytomegalovirus infection with systemic lupus erythematosus
38. Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-A*11:01
39. SHEAR saliva collection device augments sample properties for improved analytical performance.
40. Single shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad and durable systemic and mucosal immune responses
41. The molecular basis for dysfunctional bacterial lipopolysaccharide-mediated immune receptor activation by SARS-CoV-2 spike
42. Defining neutralization and allostery by antibodies against COVID-19 variants
43. Switching Heavy Chain Constant Domains Denatures the Paratope 3D Architecture of Influenza Monoclonal Antibodies
44. Efficient recall of SARS‐CoV‐2 variant‐reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters
45. SARS-CoV-2 Antibody Effectiveness Is Influenced by Non-Epitope Mutation/Binding-Induced Denaturation of the Epitope 3D Architecture
46. SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade
47. Immune and pathophysiologic profiling of antenatal coronavirus disease 2019 in the GIFT cohort: A Singaporean case-control study
48. C1q Assay to Determine Complement Fixing of Anti-Human Leukocyte Antigen Antibodies, but not Immunoglobulin Subclass Identification, Allows Better Prediction of Kidney Allograft Outcomes in an Asian Population
49. The Role of Heat Shock Proteins in the Elicitation of Immune Responses
50. Publisher Correction: A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.